Tim13B inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the Tim13B protein, a component of the mitochondrial translocase complex that plays a key role in the import and assembly of precursor proteins into the mitochondria. These inhibitors function by binding to critical regions of the Tim13B protein, such as its substrate-binding site or other domains necessary for its role in mediating protein import. By occupying these regions, Tim13B inhibitors block the protein's ability to facilitate the transport of precursor proteins across the mitochondrial membranes, thereby disrupting the protein's normal function. Some Tim13B inhibitors may also act allosterically, binding to regions of the protein away from the active site and inducing conformational changes that reduce or eliminate the protein's activity. The inhibitors form stable complexes with Tim13B through non-covalent interactions, such as hydrogen bonding, van der Waals forces, hydrophobic interactions, and ionic bonds, which ensure effective and selective inhibition of the protein's function.
Structurally, Tim13B inhibitors exhibit considerable diversity, allowing them to interact precisely with different regions of the protein. These inhibitors often incorporate functional groups such as hydroxyl, carboxyl, or amine groups, which enable them to form strong hydrogen bonds and ionic interactions with the amino acid residues in the protein's binding pockets. Additionally, many Tim13B inhibitors feature aromatic rings or heterocyclic structures that enhance hydrophobic interactions with non-polar regions of the protein, further stabilizing the inhibitor-protein complex. The physicochemical properties of Tim13B inhibitors, including molecular weight, solubility, lipophilicity, and polarity, are carefully optimized to ensure that they bind effectively and remain stable in various biological environments. By balancing hydrophilic and hydrophobic regions, Tim13B inhibitors can interact with both polar and non-polar regions of the protein, ensuring robust and efficient inhibition of Tim13B activity in diverse cellular contexts.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
This compound intercalates into DNA, specifically hindering the elongation step of RNA synthesis, which could result in the decreased transcription of the Tim13B gene. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $95.00 $322.00 $663.00 $1438.00 | 6 | |
Although primarily targeting bacterial RNA polymerase, in a hypothetical scenario, if Tim13B expression is indirectly linked to bacterial signals, Rifampicin could reduce its expression by clearing the bacterial infection. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
By inhibiting histone deacetylase, Trichostatin A promotes chromatin expansion, possibly leading to the silencing of genes that are typically upregulated; this could extend to the reduced expression of Tim13B by altering chromatin state. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound incorporates into DNA and RNA, inhibiting DNA methyltransferase which could lead to hypomethylation and silencing of the Tim13B gene, thereby reducing its expression. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Doxorubicin binds to DNA and inhibits topoisomerase II, preventing the relaxation of supercoiled DNA which is necessary for transcription; this could lead to a decrease in Tim13B mRNA synthesis. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine can intercalate into DNA and RNA, which might disrupt transcription and translation machinery, potentially leading to a decrease in Tim13B protein synthesis. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
This toxin selectively inhibits RNA polymerase II, which could specifically result in the downregulation of Tim13B mRNA transcription in eukaryotic cells. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
By binding to specific DNA sequences, particularly those rich in guanine-cytosine content, Mithramycin A could block the transcription initiation complex formation on the Tim13B promoter, decreasing its gene expression. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
DRB selectively inhibits the phosphorylation of RNA polymerase II, leading to transcriptional elongation arrest, which could downregulate Tim13B mRNA accumulation. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
This compound disrupts eukaryotic ribosomal translocation, which could indirectly downregulate Tim13B expression by inhibiting the synthesis of proteins necessary for its transcription. |